Last quarter (Q4 2023), Arcus Biosciences's total revenue was $31.00M, a decrease of -7.89% from the same quarter last year. In Q4, Arcus Biosciences's net income was $-81.00M. See Arcus Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 117.00M	$ 117.00M	$ 112.00M	$ 383.00M	$ 77.52M	$ 15.00M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 117.00M	$ 117.00M	$ 112.00M	$ 383.00M	-	-
Operating Expense	$ 457.00M	$ 457.00M	$ -392.00M	$ -329.00M	$ 201.75M	$ 103.71M
Operating Income	$ -340.00M	$ -340.00M	$ -280.00M	$ 54.00M	$ -124.23M	$ -88.71M
Net Non Operating Interest Income Expense	$ 8.00M	-	$ 14.00M	$ 1.00M	$ 1.38M	$ 5.20M
Other Income Expense	$ -31.00M	$ -39.00M	-	-	-	$ -1.20M
Pretax Income	$ -301.00M	$ -301.00M	$ -266.00M	$ 55.00M	$ -122.86M	$ -84.71M
Tax Provision	$ 6.00M	$ 6.00M	$ 1.00M	$ 2.00M	$ 0.00	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -307.00M	$ -307.00M	$ -267.00M	$ 53.00M	$ -122.86M	$ -84.71M
Basic EPS	$ -4.15	$ -4.15	$ -3.71	$ 0.76	$ -2.24	$ -1.93
Diluted EPS	$ -4.15	$ -4.15	$ -3.71	$ 0.71	$ -2.24	$ -1.93
Basic Average Shares	$ 296.00M	$ 74.00M	$ 72.00M	$ 69.30M	$ 54.79M	$ 43.83M
Diluted Average Shares	$ 296.00M	$ 74.00M	$ 72.00M	$ 74.00M	$ 54.79M	$ 43.83M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 457.00M	$ 457.00M	$ -392.00M	$ -329.00M	$ 201.75M	$ 103.71M
Net Income From Continuing And Discontinued Operation	$ -307.00M	$ -307.00M	$ -267.00M	$ 53.00M	$ -122.86M	$ -84.71M
Normalized Income	$ -176.17M	$ -237.79M	-	-	$ -123.47M	$ -84.71M
Interest Expense	-	-	-	-	$ 0.00	-
EBIT	$ -301.00M	$ -301.00M	$ -266.00M	$ 55.00M	$ -122.86M	$ -88.71M
EBITDA	$ -304.00M	$ -304.00M	$ -252.00M	$ 67.00M	$ -119.71M	$ -85.13M

Currency in USD

Arcus Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing